Stay updated on Gene Transfer Clinical Trial in Crigler-Najjar Syndrome
Sign up to get notified when there's something new on the Gene Transfer Clinical Trial in Crigler-Najjar Syndrome page.

Latest updates to the Gene Transfer Clinical Trial in Crigler-Najjar Syndrome page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe clinical trial record is displayed instead of an error page, providing details about the AT342 gene-transfer study for Crigler-Najjar syndrome, including its design, eligibility criteria, outcomes, and locations.SummaryDifference47%

- Check18 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA sitewide banner announces a transition in NIH terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe site revision displayed in the footer was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the full study record and related content with an access-restricted page, signaling that the record cannot be viewed at this time.SummaryDifference18%

Stay in the know with updates to Gene Transfer Clinical Trial in Crigler-Najjar Syndrome
Enter your email address, and we'll notify you when there's something new on the Gene Transfer Clinical Trial in Crigler-Najjar Syndrome page.